Gene: ZNF20
Official Full Name: zinc finger protein 20provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34731 | ZNF20 Knockout cell line (HeLa) | Human | ZNF20 | 1:3~1:6 | Negative | Online Inquiry |
ZNF20 Gene Knockout Cell Lines are precision-engineered cellular models designed for the study of the ZNF20 gene, a transcription factor known to play critical roles in gene regulation and cellular differentiation. By utilizing CRISPR-Cas9 technology, these cell lines effectively disable the expression of the ZNF20 gene, allowing researchers to investigate its function and downstream effects in various biological contexts.
The key function of ZNF20 Gene Knockout Cell Lines is their ability to create a controlled environment where the impacts of ZNF20 deficiency can be examined. By studying these knockout cells, scientists can elucidate ZNF20's role in cellular pathways, its involvement in diseases such as cancer, and its potential influence on epigenetic modifications. Such insights can significantly advance our understanding of gene regulation mechanisms and disease pathogenesis.
The scientific importance of ZNF20 Gene Knockout Cell Lines extends to both research and clinical applications. These models provide invaluable tools for drug discovery, biomarker identification, and the development of therapeutic strategies. By offering a specific model to study ZNF20-related pathways, they aid in dissecting the complexities of gene interaction networks, which is essential for tailoring precision medicine approaches.
In comparison to traditional gene silencing methods, such as siRNA, the ZNF20 Gene Knockout Cell Lines offer more stable and long-lasting gene inactivation, which is particularly advantageous for long-term studies and functional assays. Furthermore, the precision of the CRISPR-Cas9 technology minimizes off-target effects, ensuring greater reliability in experimental outcomes.
Researchers and clinicians stand to gain significant insights through the use of ZNF20 Gene Knockout Cell Lines, as they facilitate a deeper understanding of cellular processes and provide a platform for innovative research that can lead to new therapeutic developments.
With a commitment to excellence in genetic research tools, our company brings years of expertise in developing high-quality cellular models that empower scientists to push the boundaries of biological research and achieve impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.